会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 121. 发明授权
    • Plasma display panel, manufacturing method thereof, and plasma display
    • 等离子体显示面板,其制造方法和等离子显示器
    • US06580227B2
    • 2003-06-17
    • US10112725
    • 2002-04-02
    • Koji Kobayashi
    • Koji Kobayashi
    • H05B3700
    • H01J11/32H01J11/12H01J11/24H01J2211/245H01J2211/323
    • A mesh barrier rib structure to separate display cells is provided, and each of the display cells is completely separated from the adjacent cells. Bus electrodes are provided to overlap transparent electrodes. The bus electrodes are for example made of a layered body including a white Ag thin film and a black RuO2 thin film. The transparent electrode and the bus electrode form a scan electrode, while the transparent electrode and the bus electrode form a common electrode. The bus electrodes are provided in the closest positions to the surface discharge gap between the transparent electrodes. Therefore, priming discharge is generated in the vicinity of the discharge gap, and light emission can be restrained in the priming period.
    • 提供了用于分离显示单元的网状隔壁结构,并且每个显示单元与相邻单元完全分离。 提供总线电极以重叠透明电极。 总线电极例如由包括白色Ag薄膜和黑色RuO 2薄膜的层状体制成。 透明电极和总线电极形成扫描电极,而透明电极和总线电极形成公共电极。 总线电极设置在与透明电极之间的表面放电间隙最接近的位置。 因此,在放电间隙附近产生引发放电,能够在启动期间抑制发光。
    • 122. 发明授权
    • Container for measurement of cell functions, kit for measurement of cell functions and method for measuring cell functions
    • 用于测量细胞功能的容器,用于测量细胞功能的试剂盒和测量细胞功能的方法
    • US06468734B2
    • 2002-10-22
    • US09753518
    • 2001-01-04
    • Koji KobayashiYuji SetoguchiKiyoshi Kuriyama
    • Koji KobayashiYuji SetoguchiKiyoshi Kuriyama
    • G01N3350
    • G01N33/6869G01N33/96Y10S435/809Y10S435/81Y10S435/969Y10S435/97Y10S435/971Y10S435/973Y10S435/974Y10S436/81
    • An object is to obtain a container for measurement of cell functions which is simplified in operation, less risky and capable of measuring the cell functions very accurately. A container for measurement of cell functions, for use in the determination of a physiologically active substance produced by blood cells, is constituted such that an amount of material capable of inducing production of the physiologically active substance, when extracted by collecting water of a volume equal to a liquid volume to be subjected to measurement, is controlled at a level insufficient to induce production of the physiologically active substance from the blood cells. A container for measurement of cell functions in which a material capable of inducing production of a physiologically active substance in blood when contacted with the blood is accommodated in such a condition as being contactable with blood, and in which an amount of the material capable of inducing production of the physiologically active substance in the container before use is limited to a level insufficient to influence a measured value of the physiologically active substance.
    • 本发明的目的是获得用于测量细胞功能的容器,其操作简单,风险较小并且能够非常精确地测量细胞功能。1。一种用于测量细胞功能的容器,用于测定由 血细胞被构成为使得能够诱导生理生物活性物质的物质的量通过收集与待测量的液体体积相同的体积的水进行提取时被控制在不足以诱导生产 来自血细胞的生理活性物质。 用于测量细胞功能的容器,其中当与血液接触时能够诱导在血液中产生生理活性物质的物质的容器被容纳在与血液接触的状态下,并且其中能够诱导的物质的量 在使用前将容器中的生理活性物质的产生限制在不足以影响生理活性物质的测定值的水平。
    • 124. 发明授权
    • Pattern extraction apparatus
    • 模式提取装置
    • US06195460B1
    • 2001-02-27
    • US09297537
    • 1999-04-30
    • Koji KobayashiHiroshi NakajimaTakafumi AokiMasayuki KawamataTatsuo Higuchi
    • Koji KobayashiHiroshi NakajimaTakafumi AokiMasayuki KawamataTatsuo Higuchi
    • G06K946
    • G06K9/522
    • Collation Fourier image data (FIG. 1D) FB generated by performing the two-dimensional discrete Fourier transform (DFT) for the image data (FIG. 1C) of a collation pattern is synthesized with registration Fourier image data (FIG. 1B) generated by performing the two-dimensional DFT for the image data of a registration pattern. After amplitude suppression processing is performed for the resultant data, two-dimensional DFT is performed. A correlation peak is extracted from a correlation component area which appears in the synthesized Fourier image data (FIG. 1E) for which the two-dimensional DFT has been performed. A predetermined area including this correlation peak is then masked (FIG. 1F). The two-dimensional DFT is performed for the masked synthesized Fourier image data, and amplitude restoration processing is performed for the data. The resultant data is re-synthesized with the registration Fourier image data FA, and the two-dimensional IDFT is performed for the synthesized data. With this processing, image data containing a difference pattern like the one shown in FIG. 1G or a moving pattern can be obtained.
    • 通过对核对图案的图像数据(图1C)执行二维离散付里叶变换(DFT)生成的核对付里叶图像数据(图1D),由登记付里叶图象数据(图1B)合成, 对注册图案的图像数据执行二维DFT。 在对所得数据进行幅度压缩处理之后,执行二维DFT。 从出现在执行了二维DFT的合成付里叶图像数据(图1E)中的相关分量区域提取相关峰值。 然后掩蔽包括该相关峰的预定区域(图1F)。 对被掩蔽的合成付里叶图像数据执行二维DFT,并且对数据执行幅度恢复处理。 所得到的数据与登记付里叶图象数据FA重新合成,并且对合成数据执行二维IDFT。 通过该处理,包含类似于图1所示的差异模式的图像数据。 可以获得1G或移动图案。
    • 125. 发明授权
    • 1,2-DI-substituted piperidine derivative, hair growth promoter and
external composition for skin using the same
    • 1,2-DI取代的哌啶衍生物,毛发生长促进剂和使用其的皮肤外用组合物
    • US6057337A
    • 2000-05-02
    • US239960
    • 1999-01-29
    • Koji KobayashiHirotada FukunishiKenichi UmishioAkihiro Ishino
    • Koji KobayashiHirotada FukunishiKenichi UmishioAkihiro Ishino
    • C07D211/22C07D211/26C07D401/12C07D521/00A61K7/06
    • C07D231/12C07D211/22C07D211/26C07D233/56C07D249/08C07D401/12
    • A 1,2-di-substituted piperidine derivative or a salt thereof expressed by the following Formula (I): ##STR1## wherein one of A and B is a hydrocarbon group of C.sub.1-30 expressed by R.sup.1 and the other is --(CH.sub.2)n-NR.sup.2 R.sup.3 ; Y is --CO--, --CONR.sup.5 -- or --COO--; Z is --O--, --OCO--, --OCONR.sup.6 -- or --NR.sup.6 --; R.sup.2 and R.sup.3 individually represent a hydrogen a lower alkyl, a phenyl or a benzyl group, or together represent a heterocycle having 3-7 members; --NR.sup.5 --(CH.sub.2)n-NR.sup.2 R.sup.3 and --NR.sup.6 --(CH.sub.2)n-NR.sup.2 R.sup.3 of --(Y).sub.1 --A and --Z--B may be the following Group W: ##STR2## wherein ring E is a heterocycle of 6 or 7 members including two nitrogen atoms and R.sup.2 is a hydrogen, a lower alkyl, a phenyl or a benzyl group; R.sup.4 is a hydrogen, a halogen, a lower alkyl, a lower acyl, a nitro, a cyano, a lower alkoxycarbonyl, a carbamoyl, a lower alkylcarbamoyl, a lower alkylamino, a lower acylamino, a lower alkoxy or a lower acyloxy group; each of R.sup.5 and R.sup.6 is a hydrogen, a lower alkyl, a lower acyl, a lower alkylcarbamoyl group, or a part of said ring E; l is 0 or 1; m is an integer of 2-5; and n is an integer of 0-5. The 1,2-di-substituted piperidine derivative or the salt thereof has excellent hair growth and regrowth promoting effects, which are useful for care, improvement or prevention of hair loss in mammals and, in particular, in human.
    • 由下式(I)表示的1,2-二取代的哌啶衍生物或其盐:其中A和B中的一个为由R1表示的C1-30的烃基,另一个为 - (CH 2)n - NR2R3; Y是-CO - , - CONR 5 - 或-COO-; Z是-O - , - OCO - , - OCONR 6 - 或-NR 6 - ; R2和R3各自表示氢,低级烷基,苯基或苄基,或一起表示具有3-7个成员的杂环; - (Y)1-A和-ZB的-NR 5 - (CH 2)n -NR 2 R 3和-NR 6 - (CH 2)n -NR 2 R 3可以是以下W组:其中环E是6或7个成员的杂环,包括两个 氮原子,R 2为氢,低级烷基,苯基或苄基; R4是氢,卤素,低级烷基,低级酰基,硝基,氰基,低级烷氧基羰基,氨基甲酰基,低级烷基氨基甲酰基,低级烷基氨基,低级酰基氨基,低级烷氧基或低级酰氧基。 R5和R6各自为氢,低级烷基,低级酰基,低级烷基氨基甲酰基或所述环E的一部分; l为0或1; m为2-5的整数; n为0-5的整数。 1,2-二取代的哌啶衍生物或其盐具有优异的毛发生长和再生长促进效果,其可用于哺乳动物,特别是人的护发,改善或预防脱发。
    • 127. 发明授权
    • Perpendicular magnetic recording medium and method for making
    • 垂直磁记录介质及其制造方法
    • US5525398A
    • 1996-06-11
    • US854892
    • 1992-03-20
    • Mitsuru TakaiKoji KobayashiJiro Yoshinari
    • Mitsuru TakaiKoji KobayashiJiro Yoshinari
    • G11B5/64G11B5/65G11B5/66G11B5/73G11B5/733G11B5/85B32B3/10B32B7/02
    • G11B5/85G11B5/66Y10S428/90Y10T428/24355Y10T428/24942Y10T428/265
    • A perpendicular magnetic recording medium has a magnetic layer comprised of two stacked sublayers each in the form of ferromagnetic metal thin film consisting of columnar crystal grains wherein the angle .theta. between the average growth direction of the columnar crystal grains and a normal to the substrate is .theta..gtoreq.45.degree. for the lower sublayer and .theta..ltoreq.30.degree. for the upper sublayer, and the mean maximum diameter of columnar crystal grains of the lower sublayer is not smaller than the mean maximum diameter of columnar crystal grains of the upper sublayer. An apparatus suitable for the evaporation of the magnetic layer is arranged as shown in the Figure. Magnetic flux associated with the upper sublayer finds an escape to the lower sublayer, preventing formation of a closed loop of magnetic flux within the columnar crystal grains of the upper sublayer. The lower sublayer is magnetized, thus contributing to an improvement in reproduction output.
    • 垂直磁记录介质具有由两个堆叠的子层组成的磁性层,每个层叠子层由柱状晶粒构成的强磁性金属薄膜形式,其中柱状晶粒的平均生长方向与基板的法线之间的角度θ为θ > / = 45°,下层的θ= 30°,下层的柱状晶粒的平均最大直径不小于上层的柱状晶粒的平均最大直径 。 如图所示,配置适合于磁性层蒸发的装置。 与上部子层相关联的磁通量向下部子层发现逃逸,从而防止在上部子层的柱状晶粒内形成磁通的闭环。 下部子层被磁化,因此有助于再现输出的改善。
    • 129. 发明授权
    • Oxazinone derivative
    • 恶嗪酮衍生物
    • US5332734A
    • 1994-07-26
    • US956029
    • 1992-12-10
    • Koji KobayashiShunichi ManabeYoshihiro WatanabeKazuhide HayakawaItsuo Uchida
    • Koji KobayashiShunichi ManabeYoshihiro WatanabeKazuhide HayakawaItsuo Uchida
    • C07D265/22C07D413/12C07D417/12C07D471/04C07D239/95A61K31/535A61K31/54C07D239/72
    • C07D265/22C07D413/10C07D417/12C07D471/04
    • Disclosed is a novel oxazinone derivative represented by formula (I) given below or a pharmaceutically acceptable acid-addition salt thereof, which is useful as an anti-inflammatory agent, an agent for suppressing neutrophil infiltration and as a serine protease inhibitor: ##STR1## where A includes, for example, ##STR2## in which W is --O--, --S--, --CH.dbd.CH-- or --NR.sup.9 -- or means that (CH.sub.2).sub.n is directly bonded to (CH.sub.2).sub.n,V.sup.2 is .dbd.CR.sup.12 -- or .dbd.N--, andD is 5 to 7-membered carbon ring or hetero ring;X is --O--, --S--, --CO--, or --NR.sup.15 or means that A is directly bonded to (CH.sub.2).sub.l ;Y is --O--, --CH.dbd.CH-- or --NR.sup.16 -- or means that (CH.sub.2).sub.l is directly bonded to Z;Z is --CH.sub.2 -- or --CO--; andl is an integer of 0 to 4.Further, R and R.sup.1 to R.sup.16 are hydrogen atom, lower alkyl group, etc.
    • PCT No.PCT / JP92 / 00444 Sec。 371日期:1992年12月10日 102(e)日期1992年12月10日PCT提交1992年4月9日PCT公布。 出版物WO92 / 18488 日期:1992年10月29日。公开是由下述式(I)表示的新型恶嗪酮衍生物或其药学上可接受的酸加成盐,其可用作抗炎剂,抑制嗜中性粒细胞浸润的药剂 丝氨酸蛋白酶抑制剂:其中A包括例如其中W是-O - , - S - , - CH = CH-或-NR 9 - 的,或意味着(CH 2)n直接 键合到(CH 2)n,V 2是= CR 12 - 或= N-,D是5至7元碳环或杂环; X是-O - , - S - , - CO-或-NR 15或意指A直接键合到(CH 2)l; Y是-O - , - CH = CH-或-NR 16 - 或意指(CH 2)l直接键合到Z上; Z是-CH 2 - 或-CO-; l为0〜4的整数。另外,R和R 1〜R 16为氢原子,低级烷基等。